Isabelle Quintin-Roué - JoVE Visualize

Showing results (21-30 of 37) with videos related to

Pageof 4

Sort By:

Oncology Reports|July 28, 2016

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issuesArnaud Uguen, Sophie Andrieu-Key, Florence Vergne, et al.

Journal of Neuro-Oncology|October 4, 2005

Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice modelJean-François Mineo, Anne Bordron, Isabelle Quintin-Roué, et al.

Clinical and Experimental Rheumatology|February 25, 2011

Effects of rituximab therapy on quality of life in patients with primary Sjögren's syndromeValérie Devauchelle-Pensec, Johanne Morvan, Anne-Christine Rat, et al.

Leukemia & Lymphoma|May 10, 2017

The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomesLenaïg Le Clech, Mehdi Sakka, Ahmed Meskar, et al.

Arthritis and Rheumatism|March 3, 2007

Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20)Valérie Devauchelle-Pensec, Yvon Pennec, Johanne Morvan, et al.

Biologics : Targets & Therapy|August 27, 2009

Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: Quantitative and Doppler waveform analysisSandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Johanne Morvan, et al.

Pathology|September 14, 2021

Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencingAmélie Bourhis, Charline Caumont, Isabelle Quintin-Roué, et al.

Rheumatology (Oxford, England)|November 30, 2014

Reliability of histopathological salivary gland biopsy assessment in Sjögren's syndrome: a multicentre cohort studySebastian Costa, Isabelle Quintin-Roué, Agnès Lesourd, et al.

Arthritis Research & Therapy|January 21, 2016

B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureSebastian Costa, Sacha Schutz, Divi Cornec, et al.

Frontiers in Nuclear Medicine|October 2, 2024

Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell LymphomaVincent Rebière, Meriem Maajem, Ronan Le Calloch, et al.

Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:

Pageof 4

Oncology Reports|July 28, 2016

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issuesArnaud Uguen, Sophie Andrieu-Key, Florence Vergne, et al.

Journal of Neuro-Oncology|October 4, 2005

Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice modelJean-François Mineo, Anne Bordron, Isabelle Quintin-Roué, et al.

Clinical and Experimental Rheumatology|February 25, 2011

Effects of rituximab therapy on quality of life in patients with primary Sjögren's syndromeValérie Devauchelle-Pensec, Johanne Morvan, Anne-Christine Rat, et al.

Leukemia & Lymphoma|May 10, 2017

The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomesLenaïg Le Clech, Mehdi Sakka, Ahmed Meskar, et al.

Arthritis and Rheumatism|March 3, 2007

Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20)Valérie Devauchelle-Pensec, Yvon Pennec, Johanne Morvan, et al.

Biologics : Targets & Therapy|August 27, 2009

Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: Quantitative and Doppler waveform analysisSandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Johanne Morvan, et al.

Pathology|September 14, 2021

Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencingAmélie Bourhis, Charline Caumont, Isabelle Quintin-Roué, et al.

Rheumatology (Oxford, England)|November 30, 2014

Reliability of histopathological salivary gland biopsy assessment in Sjögren's syndrome: a multicentre cohort studySebastian Costa, Isabelle Quintin-Roué, Agnès Lesourd, et al.

Arthritis Research & Therapy|January 21, 2016

B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedureSebastian Costa, Sacha Schutz, Divi Cornec, et al.

Frontiers in Nuclear Medicine|October 2, 2024

Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell LymphomaVincent Rebière, Meriem Maajem, Ronan Le Calloch, et al.

Pageof 4